These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2184731)

  • 41. Calcium antagonists and the kidney. Implications for renal protection.
    Epstein M
    Am J Hypertens; 1993 Jul; 6(7 Pt 2):251S-259S. PubMed ID: 8398009
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcium antagonists and the kidney: future therapeutic perspectives.
    Epstein M
    Am J Kidney Dis; 1993 Jun; 21(6 Suppl 3):16-25. PubMed ID: 8503430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calcium antagonists and renal protection. Current status and future perspectives.
    Epstein M
    Arch Intern Med; 1992 Aug; 152(8):1573-84. PubMed ID: 1497390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular mechanism of ischemic acute renal failure: role of Ca2+ and calcium entry blockers.
    Schrier RW; Hensen J
    Klin Wochenschr; 1988 Sep; 66(18):800-7. PubMed ID: 2846945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium antagonists and the kidney.
    Loutzenhiser RD; Epstein M
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):154S-161S. PubMed ID: 2665786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal hemodynamic effects of calcium antagonists.
    Loutzenhiser RD; Epstein M
    Am J Med; 1987 Mar; 82(3B):23-8. PubMed ID: 2436475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium antagonists and renal hemodynamics: implications for renal protection.
    Epstein M
    J Am Soc Nephrol; 1991 Aug; 2(2 Suppl 1):S30-6. PubMed ID: 1932641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium antagonists and acute renal failure.
    Russell JD; Churchill DN
    Am J Med; 1989 Sep; 87(3):306-15. PubMed ID: 2672810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal protective aspects of calcium antagonists. International Workshop. Florence, Italy, April 14-16, 1991. Proceedings.
    Kidney Int Suppl; 1992 May; 36():S1-118. PubMed ID: 1351956
    [No Abstract]   [Full Text] [Related]  

  • 50. Cellular calcium in ischemic acute renal failure: role of calcium entry blockers.
    Schrier RW; Arnold PE; Van Putten VJ; Burke TJ
    Kidney Int; 1987 Sep; 32(3):313-21. PubMed ID: 3312759
    [No Abstract]   [Full Text] [Related]  

  • 51. Effects of calcium antagonists on renal function.
    Bauer JH; Reams GP
    Ann N Y Acad Sci; 1988; 522():785-92. PubMed ID: 3288069
    [No Abstract]   [Full Text] [Related]  

  • 52. Non-vascular central nervous system effects of calcium entry blockers.
    Govoni S; Battaini F; Magnoni MS; Trabucchi M
    Cephalalgia; 1985 May; 5 Suppl 2():115-8. PubMed ID: 2861906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New pharmacologic options for renal preservation.
    Garwood S
    Anesthesiol Clin North Am; 2000 Dec; 18(4):753-71. PubMed ID: 11094689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Is the prevention of acute drug induced nephrotoxicity possible?].
    Deray G; Baumelou A
    Presse Med; 1988 Sep; 17(32):1607-8. PubMed ID: 2973010
    [No Abstract]   [Full Text] [Related]  

  • 55. Renal protective effects of calcium antagonists?
    Bauer JH
    Cardiovasc Drugs Ther; 1987 Dec; 1(4):349-51. PubMed ID: 3154671
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic strategies in the prevention of acute renal failure.
    García RE
    Ren Fail; 1997 Mar; 19(2):231-5. PubMed ID: 9101598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium channel blockers: protective effects in ischemic acute renal failure.
    Wetzels JF; Burke TJ; Schrier RW
    Ren Fail; 1992; 14(3):327-32. PubMed ID: 1509165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Is nephrotoxicity of cyclosporine ineluctable?].
    Niaudet P
    Presse Med; 1994 Jun; 23(23):1061-3. PubMed ID: 7971816
    [No Abstract]   [Full Text] [Related]  

  • 59. [Status quo of experimental and clinical studies in retarding kidney damage of chronic nephropathy by ligustrazine].
    Cao WF; Li RH; Chen BX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 May; 17(5):314-5. PubMed ID: 9863118
    [No Abstract]   [Full Text] [Related]  

  • 60. [The role of calcium antagonists in nephroprotection: complex issues proved aspects and prospective studies].
    Arutiunov AG; Arutiunov GP
    Kardiologiia; 2014; 54(6):67-75. PubMed ID: 25178082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.